Summary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
Efficacy
-
-
Pharma Science & ResearchRoche
Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea
by adminby adminSummary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…
-
Global MarketPharma Science & Research
First study to show waning effectiveness of 3rd dose of mRNA vaccines
by adminby adminSummary : A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity…
-
Agrochemicals
The USFDA Grants Orphan Drug Designation to CT120 a Novel CAR T-Cell Therapy of IASO Biotherapeutics for Acute Lymphoblastic Leukemia
by adminby adminKEYPOINTS: The FDA has granted orphan drug designation (ODD) to CT120 for the treatment of acute lymphoblastic leukemia, a novel chimeric antigen…
-
Agrochemicals
BioMarin`s VOXZOGO (Vosoritide) becomes the First U.S.FDA-approved Drug Therapy for Dwarfism.
by adminby adminSynopsis: BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to VOXZOGO™ (Vosoritide) for Injection, indicated…
-
CompaniesPfizer
BioNTech Deal With Senegal, Rwanda to Make mRNA Vaccine in Mid 2022
by adminby adminSummary- BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Backed by EU…
-
Active Agrochemical IngredientAtezolizumab
USFDA approves Roche’s Tecentriq (Atezolizumab) as Adjuvant Treatment for Non- small Cell Lung Cancer.
by adminby adminKeypoints USFDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early NSCLC Tecentriq treatment reduced the risk of disease recurrence…
-
Pharma Science & Research
The USA Russell Lab Wins Grant to Develop New Tuberculosis Drugs
by adminby adminKeypoints Russell lab wins grant to develop new tuberculosis drugs. Russell lab received funding to improve the efficacy of medicines against one…